NeuroPace

📍 Mountain View, United States🗓 Founded 1999👥 211 employees💰 Last funded Jan 2025
Medical Equipment Manufacturing🌐 neuropace.com
Website LinkedIn
The RNS® System is an award-winning technology developed and manufactured in Silicon Valley that has been recognized for its innovation. Similar to a pacemaker that monitors and responds to heart rhythms, the RNS System is the worlds first and only medical device that can monitor and respond to brain activity. NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation. The companys initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.In addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world.
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
1999
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2016–2025 · investors recorded per year
201612017120251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in NeuroPace?
NeuroPace has 3 investors on record on gritt.io.
When did NeuroPace last raise funding?
The most recent investment in NeuroPace recorded on gritt.io was in January 2025.
When was NeuroPace founded?
NeuroPace was founded in 1999.
What industry is NeuroPace in?
NeuroPace operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is NeuroPace based?
NeuroPace is headquartered in Mountain View, United States.